Pfizer (PFE) Aims $15 billion from COVID-19 vaccines sales in 2021
Pfizer (PFE) stock declined slightly despite a strong earnings report on Tuesday as investors focused on the company’s quarterly results. PFE stock performance year-to-date stands at -4.94%, while its performance over the last seven days is just below -6.22%. For the past month, the stock’s price index fell by -4.94%, and over the previous three-month […]